• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和患病组织中的人类半胱氨酸蛋白酶抑制剂——综述

Human cystatins in normal and diseased tissues--a review.

作者信息

Järvinen M, Rinne A, Hopsu-Havu V K

机构信息

Department of Pathology, University of Oulu, Finland.

出版信息

Acta Histochem. 1987;82(1):5-18. doi: 10.1016/S0065-1281(87)80043-0.

DOI:10.1016/S0065-1281(87)80043-0
PMID:3122506
Abstract

Immunohistochemica and quantitative immunochemical methods were used to demonstrate the presence of two cysteine proteinase inhibitors, cystatins A and B, in normal and diseased tissues. Cystatin A is expressed in squamous epithelia, neutrophil granulocytes, and dendritic reticulum cells of the lymphatic tissues. Its concentration is increased in inflammatory skin diseases and decreases after the malignization of squamous epithelia. Cystatin B is seen in wet squamous epithelia, and in the cells of monocyte-macrophage series, where its concentration varies depending on the activation state of the cells. In the malignant keratinocytes cystatin B follows the behaviour of cystatin A.

摘要

采用免疫组织化学和定量免疫化学方法,在正常组织和病变组织中证实两种半胱氨酸蛋白酶抑制剂——胱抑素A和胱抑素B的存在。胱抑素A在鳞状上皮、中性粒细胞和淋巴组织的树突状网状细胞中表达。其浓度在炎症性皮肤病中升高,在鳞状上皮恶变后降低。胱抑素B见于湿润的鳞状上皮以及单核细胞-巨噬细胞系列细胞中,其浓度随细胞的激活状态而变化。在恶性角质形成细胞中,胱抑素B的表现与胱抑素A一致。

相似文献

1
Human cystatins in normal and diseased tissues--a review.正常和患病组织中的人类半胱氨酸蛋白酶抑制剂——综述
Acta Histochem. 1987;82(1):5-18. doi: 10.1016/S0065-1281(87)80043-0.
2
Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75-1.
Neoplasma. 1989;36(2):185-9.
3
[Cystatins].[胱抑素]
Postepy Biochem. 1987;33(2-3):231-41.
4
The cystatins: small protein inhibitors of cysteine proteinases.
Prog Clin Biol Res. 1985;180:105-16.
5
Cysteine proteinase inhibitors in inflamed human gingiva.
Biol Chem Hoppe Seyler. 1988 May;369 Suppl:271-6.
6
[Low-molecular cysteine protease inhibitors in the human palatal tonsil].[人腭扁桃体中的低分子半胱氨酸蛋白酶抑制剂]
Anat Anz. 1986;161(3):215-30.
7
Detection of low molecular weight cysteine proteinase inhibitors by time-resolved fluoroimmunoassay.通过时间分辨荧光免疫测定法检测低分子量半胱氨酸蛋白酶抑制剂
J Immunol Methods. 1986 Feb 12;86(2):243-7. doi: 10.1016/0022-1759(86)90460-6.
8
Diagnostic value of analysis of cystatin C and protein HC in biological fluids.生物体液中胱抑素C和蛋白HC分析的诊断价值。
Clin Nephrol. 1992;38 Suppl 1:S20-7.
9
Prediction of the secondary structures of stefins and cystatins, the low-molecular mass protein inhibitors of cysteine proteinases.
Biol Chem Hoppe Seyler. 1987 May;368(5):493-9. doi: 10.1515/bchm3.1987.368.1.493.
10
The cystatins: a diverse superfamily of cysteine peptidase inhibitors.胱抑素:一个多样化的半胱氨酸肽酶抑制剂超家族。
Biomed Biochim Acta. 1986;45(11-12):1363-74.

引用本文的文献

1
Association of Cystatin C Proteoforms with Estimated Glomerular Filtration Rate.胱抑素C蛋白异构体与估算肾小球滤过率的关联
Clin Mass Spectrom. 2016 Nov;1:27-31. doi: 10.1016/j.clinms.2016.11.001. Epub 2016 Nov 14.
2
Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly the Epithelium Proliferation/Differentiation Program.胱抑素B负向调节口腔鳞状细胞癌的恶性特征,可能是通过上皮增殖/分化程序实现的。
Front Oncol. 2021 Aug 24;11:707066. doi: 10.3389/fonc.2021.707066. eCollection 2021.
3
Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma.
胰腺导管腺癌患者中胱抑素A表达的临床特征。
Cancer Sci. 2017 Nov;108(11):2122-2129. doi: 10.1111/cas.13396. Epub 2017 Oct 8.
4
The association of plasma cystatin C proteoforms with diabetic chronic kidney disease.血浆胱抑素C蛋白亚型与糖尿病慢性肾脏病的关联
Proteome Sci. 2016 Mar 25;14:7. doi: 10.1186/s12953-016-0096-7. eCollection 2016.
5
Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells.半胱氨酸组织蛋白酶作为自然杀伤细胞和T细胞细胞毒性的调节因子。
Front Immunol. 2014 Dec 2;5:616. doi: 10.3389/fimmu.2014.00616. eCollection 2014.
6
Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin.颗粒头样蛋白1缺失与表皮屏障破坏及皮肤鳞状细胞癌相关。
PLoS One. 2014 Feb 20;9(2):e89247. doi: 10.1371/journal.pone.0089247. eCollection 2014.
7
Deciphering c-MYC-regulated genes in two distinct tissues.解析两种不同组织中 c-MYC 调控的基因。
BMC Genomics. 2011 Sep 30;12:476. doi: 10.1186/1471-2164-12-476.
8
Targeted quantitative mass spectrometric immunoassay for human protein variants.靶向定量质谱免疫分析法检测人蛋白变异体。
Proteome Sci. 2011 Apr 8;9(1):19. doi: 10.1186/1477-5956-9-19.
9
Functional expression of recombinant human stefin A in mammalian and bacterial cells.重组人丝抑蛋白A在哺乳动物细胞和细菌细胞中的功能表达。
Protein Expr Purif. 2007 Apr;52(2):463-71. doi: 10.1016/j.pep.2006.11.020. Epub 2006 Dec 9.
10
Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.酸性半胱氨酸蛋白酶抑制剂(ACPI,胱抑素A)在非小细胞肺癌中的生物学及预后作用
J Clin Pathol. 2007 May;60(5):515-9. doi: 10.1136/jcp.2006.038711. Epub 2006 Jun 21.